Roth Capital Partners is acting as the Company's financial advisor for this transaction.
Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The ...
Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody ...
Occidental announced an offer to exercise its outstanding publicly traded warrants at a temporarily reduced price. The Offer is available to ...
United Lithium Corp. (“United Lithium” or the “Company”) (CSE: ULTH; OTCQX: ULTHF; FWB: 0UL) is announcing that it has applied to ...
ASHKELON, ISRAEL and VANCOUVER, BRITISH COLUMBIA - February 28, 2025 (NEWMEDIAWIRE) - Femto Technologies Inc. (Nasdaq: FMTO) ...
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...
SUNation Energy, Inc. (Nasdaq: SUNE), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results